Medi Labz
← All tools
003HematologyBeta

Clotting Cascade Lab

Break one clotting factor, then predict what PT, aPTT and bleeding time will show.

Watch · Explore · Diagnose · Quiz

Watch it. Break it. Solve it. Test it.

Watch a small cut heal second by second, then break the cascade yourself: every test answers, and so does the real question, does this patient bleed? Then solve patients from their stories and labs, and quiz yourself on the facts behind them.

Mode

Break the cascade and watch every test answer.

Picture

Normal hemostasis. Everything works: the vessel squeezes, platelets plug, the cascade builds fibrin, XIII cross-links it. (Guyton)

Press a factor to remove it. Press a test's name to see what it measures.

ExtrinsicStarts with torn tissue · PTWorking
IIITissue factorAdded in the PT tube
IntrinsicStarts on contact · aPTTWorking
CommonShared · PT and aPTTWorking

XIII cross-links the fibrin. Neither PT nor aPTT measures it.

IVCalciumNeeded at almost every step; every test adds it back
Vessel and platelets
Drugs and antibodies

Does this patient bleed?

No abnormal bleeding

  • Normal

    Reference: 10–12 s (Brown)

  • Normal

    Reference: 25–35 s (Brown, Block IV lecture)

  • Normal
  • Normal

    Reference: 2–8 min (Brown)

  • Normal

    Reference: 150,000–450,000/µL (Guyton)

  • Negative

    Reference: Up to 10 petechiae normal; 10–20 equivocal; over 20 abnormal (3 cm circle) (Block IV lab handout)

  • Clot stays solid

    Reference: Clot stays insoluble (Block IV lecture, Naderi 2013)

  • Normal

Sources

Where this comes from.

  1. Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology, 14th ed. Chapter 37: Hemostasis and Blood Coagulation. (chapter read)
  2. Brown BA. Hematology: Principles and Procedures, 6th ed. Chapter 5 (Block IV Case 2 reference packet). (chapter read)
  3. Block IV Module 1 lecture: Hemostasis and Thrombosis. (chapter read)
  4. Block IV Module 1 pathology laboratory handout: tests of hemostasis. (chapter read)
  5. Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515-23. (read in full)
  6. Hoffman M, Monroe DM. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958-65. (abstract only)
  7. Santoro RC, et al. Isolated prolongation of activated partial thromboplastin time: not just bleeding risk! Medicina. 2023;59(6):1169. (read in full)
  8. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc. 2007;82(7):864-73. (abstract only)
  9. James PD, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280-300. (abstract only)
  10. Srivastava A, et al. WFH Guidelines for the Management of Hemophilia, 3rd ed. Haemophilia. 2020;26 Suppl 6:1-158. (abstract only)
  11. Naderi M, et al. Current understanding in diagnosis and management of factor XIII deficiency. Iran J Ped Hematol Oncol. 2013;3(4):164-72. (abstract only)
  12. Nadakuditi NK, et al. Clinical profile of congenital factor XIII deficiency in children. Indian J Pediatr. 2024;91(3):223-28. (abstract only)
  13. Grande AJ, et al. Tourniquet test for dengue diagnosis: systematic review and meta-analysis of diagnostic test accuracy. PLoS Negl Trop Dis. 2016;10(8):e0004888. (read in full)
  14. Adcock DM, et al. Activated partial thromboplastin time and prothrombin time mixing studies: current state of the art. Semin Thromb Hemost. 2023;49(6):571-79. (abstract only)
  15. Rasmussen KL, et al. Unexpected, isolated activated partial thromboplastin time prolongation: a practical mini-review. Eur J Haematol. 2020;104(6):519-25. (abstract only)

Results are shown as words, not seconds, because real reference ranges differ between laboratories. Content checked by the builder (a medical student) against these sources; not yet reviewed by faculty.